These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical and serologic factors associated with lupus pleuritis. Mittoo S; Gelber AC; Hitchon CA; Silverman ED; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman DD; Urowitz MB; Zummer M; Clarke AE; Bernatsky S; Hudson M; Tucker LB; Petty RE; ; Peschken CA J Rheumatol; 2010 Apr; 37(4):747-53. PubMed ID: 20110526 [TBL] [Abstract][Full Text] [Related]
26. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Mikdashi J; Krumholz A; Handwerger B Neurology; 2005 Jun; 64(12):2102-7. PubMed ID: 15985581 [TBL] [Abstract][Full Text] [Related]
27. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD; Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840 [TBL] [Abstract][Full Text] [Related]
28. Damage in systemic lupus erythematosus and its association with corticosteroids. Zonana-Nacach A; Barr SG; Magder LS; Petri M Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870 [TBL] [Abstract][Full Text] [Related]
29. [Characterization of a Portuguese population with systemic lupus erytematosus]. Santos MJ; Capela S; Figueira R; Nero P; Matos AA; Silva C; Miranda L; Barcelos A; Marques A; Teixeira A; Branco J; da Silva JC; de Queiroz MV Acta Reumatol Port; 2007; 32(2):153-61. PubMed ID: 17576395 [TBL] [Abstract][Full Text] [Related]
30. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809 [TBL] [Abstract][Full Text] [Related]
31. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. McLaurin EY; Holliday SL; Williams P; Brey RL Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428 [TBL] [Abstract][Full Text] [Related]
32. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage. Lee PP; Lee TL; Ho MH; Wong WH; Lau YL Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097 [TBL] [Abstract][Full Text] [Related]
33. Alexithymia in systemic lupus erythematosus patients. Barbosa F; Mota C; Alves M; Alcântara C; Rossiñol B; Patrício P; Barbosa A; Ferreira C Ann N Y Acad Sci; 2009 Sep; 1173():227-34. PubMed ID: 19758155 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290 [TBL] [Abstract][Full Text] [Related]
35. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112 [TBL] [Abstract][Full Text] [Related]
36. Characterization of damage in Portuguese lupus patients: analysis of a national lupus registry. Gonçalves MJ; Sousa S; Inês LS; Duarte C; Borges J; Silva C; Romão VC; Terroso G; Bernardes M; Cerqueira M; Raposo A; Sequeira G; Barcelos A; Macieira C; Canas da Silva J; Costa L; Pereira da Silva JA; Cunha-Miranda L; Da Silva JA; Canhão H; Santos MJ Lupus; 2015 Mar; 24(3):256-62. PubMed ID: 25318970 [TBL] [Abstract][Full Text] [Related]
37. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years. Gilboe IM; Kvien TK; Husby G J Rheumatol; 2001 Feb; 28(2):266-74. PubMed ID: 11246660 [TBL] [Abstract][Full Text] [Related]
38. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort. Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965 [TBL] [Abstract][Full Text] [Related]
39. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study. Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983 [TBL] [Abstract][Full Text] [Related]
40. Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients. Jallouli M; Frigui M; Hmida MB; Marzouk S; Kaddour N; Bahloul Z Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):1001-8. PubMed ID: 18974596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]